Fuad M. Baroody
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fuad M. Baroody has a total of 777 co-authors. Here are the top co-authors by number of shared publications:
Robert M. Naclerio
Section of Otolaryngology–Head and Neck Surgery The University of Chicago Medicine and Biological Sciences Chicago IL
15 shared publicationsMarcy Detineo
Section of Otolaryngology–Head and Neck Surgery The Pritzker School of Medicine University of Chicago Chicago Illinois USA
7 shared publications- Andrea Shogan
Department of Surgery, Section of Otolaryngology University of Chicago Medicine Chicago Illinois USA
3 shared publications Lauran Haney
Section of Otolaryngology—Head and Neck Surgery, The Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, U.S.A.
3 shared publicationsMarcy DeTineo
Section of Otolaryngology–Head and Neck Surgery The University of Chicago Medicine and Biological Sciences Chicago IL
3 shared publicationsParaya Assanasen
3 shared publications
Latest Publications
- 4 July 2024
- Published by Springer Nature
- p. 1-6
History of Nasal Polyposis
- Open Access
Otolaryngology Away Subinternships: An Analysis of the Application Process and Survey of Current Applicants' Perspectives
Objective: To assess the availability and uniformity of application information for away subinternships and survey 4th‐year medical students on their experiences obtaining away subinternships in otolaryngology‐head and neck surgery (OHNS) during the 2022 to 2023 application cycle.Study Design: Cross‐sectional study.Setting: Online survey.Methods: The Association of American Medical College's Visiting Student Learning Opportunities (VSLO) program was queried for information on OHNS away subinternship applications. A survey assessing 4th‐year medical students' perceptions of the away subinternship application process was distributed via OHNS residency program directors and Otomatch.Results: Of 129 OHNS residency programs, 103 (80%) offered away subinternship opportunities on VSLO. Variability in application release dates (January 18 to June 3, 2022), offer release dates (January 27 to August 7, 2022), and estimated cost ($22‐$5500) were found. The most common application requirements were a transcript (98.1%) and a CV/resume (90.3%). There were 64 survey respondents, for a 13% response rate. The most common concerns include applying to too few programs (80%) and not knowing offer release dates (77%). The most common stressors include choosing a number of programs to which to apply (48%) and cost (35%). The majority (76%) reported difficulty finding updated information on program websites. Among the proposed changes, the greatest support was found for having all applications on VSLO (88%), uniform application release date (84%), and uniform application requirements (82%).Conclusion: The OHNS away subinternship application process is a significant source of anxiety for medical students due to the tremendous variability in application and acceptance procedures. Having all applications on VSLO, uniform application requirements, and uniform application opening and offer release dates would better facilitate this process.
Open AccessOtolaryngology Away Subinternships: An Analysis of the Application Process and Survey of Current Applicants' Perspectives
Objective: To assess the availability and uniformity of application information for away subinternships and survey 4th‐year medical students on their experiences obtaining away subinternships in otolaryngology‐head and neck surgery (OHNS) during the 2022 to 2023 application cycle.Study Design: Cross‐sectional study.Setting: Online survey.Methods: The Association of American Medical College's Visiting Student Learning Opportunities (VSLO) program was queried for information on OHNS away subinternship applications. A survey assessing 4th‐year medical students' perceptions of the away subinternship application process was distributed via OHNS residency program directors and Otomatch.Results: Of 129 OHNS residency programs, 103 (80%) offered away subinternship opportunities on VSLO. Variability in application release dates (January 18 to June 3, 2022), offer release dates (January 27 to August 7, 2022), and estimated cost ($22‐$5500) were found. The most common application requirements were a transcript (98.1%) and a CV/resume (90.3%). There were 64 survey respondents, for a 13% response rate. The most common concerns include applying to too few programs (80%) and not knowing offer release dates (77%). The most common stressors include choosing a number of programs to which to apply (48%) and cost (35%). The majority (76%) reported difficulty finding updated information on program websites. Among the proposed changes, the greatest support was found for having all applications on VSLO (88%), uniform application release date (84%), and uniform application requirements (82%).Conclusion: The OHNS away subinternship application process is a significant source of anxiety for medical students due to the tremendous variability in application and acceptance procedures. Having all applications on VSLO, uniform application requirements, and uniform application opening and offer release dates would better facilitate this process.
- Open Access
- 29 November 2022
- Published by Hindawi Limited in Case Reports in Oncological Medicine
- Vol. 2022, 1-3
Systemic Bevacizumab for Severe Recurrent Respiratory Papillomatosis
Recurrent respiratory papillomatosis (RRP) is the most common benign pediatric laryngeal neoplasm. Various adjuvant medical therapies have failed to reliably decrease surgical frequency in this challenging airway disease. Recently, systemic bevacizumab has shown promise in advanced, treatment-resistant papillomatosis. We describe the use of systemic bevacizumab in two children with severe RRP unresponsive to other therapies. Voice and breathing improved dramatically in both patients with minimal side effects. Both patients have not required surgery in 24 months and 16 months, respectively. Systemic bevacizumab is a promising long-term treatment for severe RRP, with oncology playing an important role in patient care.
- 29 November 2022
- Published by Hindawi Limited in Case Reports in Oncological Medicine
- Vol. 2022, 1-3
Open AccessSystemic Bevacizumab for Severe Recurrent Respiratory Papillomatosis
Recurrent respiratory papillomatosis (RRP) is the most common benign pediatric laryngeal neoplasm. Various adjuvant medical therapies have failed to reliably decrease surgical frequency in this challenging airway disease. Recently, systemic bevacizumab has shown promise in advanced, treatment-resistant papillomatosis. We describe the use of systemic bevacizumab in two children with severe RRP unresponsive to other therapies. Voice and breathing improved dramatically in both patients with minimal side effects. Both patients have not required surgery in 24 months and 16 months, respectively. Systemic bevacizumab is a promising long-term treatment for severe RRP, with oncology playing an important role in patient care.
- 1 June 2022
- Published by Wiley in The Laryngoscope
- Vol. 133 (3) , E7
Adenotonsillectomy Significantly Reduces Central Apneas in Patients with a Predominantly Obstructive Sleep Apnea component
- 1 June 2022
- Published by Wiley in The Laryngoscope
- Vol. 133 (3) , E7
Adenotonsillectomy Significantly Reduces Central Apneas in Patients with a Predominantly Obstructive Sleep Apnea component
- 29 July 2021
- Published by Wiley in The Laryngoscope
- Vol. 132 (2) , 478-484
Improvement in Central Sleep Apnea Following Adenotonsillectomy in Children
Objective: Previous studies examining changes in central sleep apnea (CSA) following adenotonsillectomy (T&A) performed for obstructive sleep apnea (OSA) in children have been limited by sample size and analysis of only certain populations. The aim of this study was to determine whether CSA improves following T&A and what factors mediate this change.Methods: This was a retrospective case series from 1994 to 2020 of children undergoing primary T&A for OSA (obstructive apnea‐hypopnea index ≥1) with CSA (central apnea index [CAI] ≥1) and preoperative and postoperative polysomnograms within 12 months of T&A. Polysomnograms were analyzed for improvement in CSA, defined as: 1) if preoperative CAI >5, a postoperative CAI P < .001). Thirty‐two (26.0%) patients had CSA postoperatively. Improvement in the microarousal index and older age were significantly associated with improvement in CSA.Conclusions: T&A led to resolution of CSA in most children with OSA. Improvement in the microarousal index was associated with improvement in CAI, suggesting that preoperative central apneas may be postarousal and thus resolve following T&A.Level of Evidence: 4 Laryngoscope, 132:478–484, 2022
- 29 July 2021
- Published by Wiley in The Laryngoscope
- Vol. 132 (2) , 478-484
Improvement in Central Sleep Apnea Following Adenotonsillectomy in Children
Objective: Previous studies examining changes in central sleep apnea (CSA) following adenotonsillectomy (T&A) performed for obstructive sleep apnea (OSA) in children have been limited by sample size and analysis of only certain populations. The aim of this study was to determine whether CSA improves following T&A and what factors mediate this change.Methods: This was a retrospective case series from 1994 to 2020 of children undergoing primary T&A for OSA (obstructive apnea‐hypopnea index ≥1) with CSA (central apnea index [CAI] ≥1) and preoperative and postoperative polysomnograms within 12 months of T&A. Polysomnograms were analyzed for improvement in CSA, defined as: 1) if preoperative CAI >5, a postoperative CAI P < .001). Thirty‐two (26.0%) patients had CSA postoperatively. Improvement in the microarousal index and older age were significantly associated with improvement in CSA.Conclusions: T&A led to resolution of CSA in most children with OSA. Improvement in the microarousal index was associated with improvement in CAI, suggesting that preoperative central apneas may be postarousal and thus resolve following T&A.Level of Evidence: 4 Laryngoscope, 132:478–484, 2022
- Open Access
- 1 August 2020
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 231 (2) , 205-215
Pediatric Modification of the Medically Necessary, Time-Sensitive Scoring System for Operating Room Procedure Prioritization During the COVID-19 Pandemic
The COVID-19 pandemic forced surgeons to reconsider concepts of "elective" surgery. Perceptions regarding the time-sensitivity and medical necessity of a procedure have taken on greater significance during the pandemic. The evolving ethical and clinical environment requires reappraisal of perioperative factors such as personal protective equipment conservation; limiting the risk of exposure to COVID-19 for patients, families, and health care workers; preservation of hospital beds and intensive care unit resources; and minimizing COVID-19 related perioperative risk to patients. A scaffold for the complex decision-making required for prioritization of Medically Necessary, Time Sensitive (MeNTS) surgeries was developed for adult patients by colleagues at The University of Chicagoi. Although adult MeNTS scoring can be applied across adult surgical specialties, some variables were irrelevant in a pediatric population. Pediatric manifestations of chronic diseases and congenital anomalies were not accounted for. In order to account for the unique challenges children face, we modified the adult MeNTS system for use across pediatric subspecialties. This Pediatric MeNTS (pMeNTS) scoring system was applied to 101 cases both performed and deferred between March 23rd and April 19th, 2020, at The University of Chicago Comer Children's Hospital. The pMeNTS scores provides a safe, equitable, transparent, and ethical strategy to prioritize children's surgical procedures. This process is adaptable to individual institutions, and we project it will be useful during the acute phase of the pandemic (maximal limitations) as well as the anticipated recovery phase.
- 1 August 2020
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 231 (2) , 205-215
Open AccessPediatric Modification of the Medically Necessary, Time-Sensitive Scoring System for Operating Room Procedure Prioritization During the COVID-19 Pandemic
The COVID-19 pandemic forced surgeons to reconsider concepts of "elective" surgery. Perceptions regarding the time-sensitivity and medical necessity of a procedure have taken on greater significance during the pandemic. The evolving ethical and clinical environment requires reappraisal of perioperative factors such as personal protective equipment conservation; limiting the risk of exposure to COVID-19 for patients, families, and health care workers; preservation of hospital beds and intensive care unit resources; and minimizing COVID-19 related perioperative risk to patients. A scaffold for the complex decision-making required for prioritization of Medically Necessary, Time Sensitive (MeNTS) surgeries was developed for adult patients by colleagues at The University of Chicagoi. Although adult MeNTS scoring can be applied across adult surgical specialties, some variables were irrelevant in a pediatric population. Pediatric manifestations of chronic diseases and congenital anomalies were not accounted for. In order to account for the unique challenges children face, we modified the adult MeNTS system for use across pediatric subspecialties. This Pediatric MeNTS (pMeNTS) scoring system was applied to 101 cases both performed and deferred between March 23rd and April 19th, 2020, at The University of Chicago Comer Children's Hospital. The pMeNTS scores provides a safe, equitable, transparent, and ethical strategy to prioritize children's surgical procedures. This process is adaptable to individual institutions, and we project it will be useful during the acute phase of the pandemic (maximal limitations) as well as the anticipated recovery phase.
- 28 September 2019
- Published by Springer Nature
- p. 139-148
Pediatric Rhinosinusitis and Gastroesophageal Reflux
- 28 September 2019
- Published by Springer Nature
- p. 139-148
Pediatric Rhinosinusitis and Gastroesophageal Reflux
- 28 September 2019
- Published by Springer Nature
- p. 189-199
Medical Treatment of Pediatric Rhinosinusitis: Focus on Intranasal and Systemic Corticosteroids
- 28 September 2019
- Published by Springer Nature
- p. 189-199
Medical Treatment of Pediatric Rhinosinusitis: Focus on Intranasal and Systemic Corticosteroids